Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DAVITA INC. | 56,506 | reported | 15 Mar 2026 | tx 196+8,705,964−8,638,704 |
| BioXcel Therapeutics, Inc. | 26,803 | reported | 20 May 2026 | tx 74+278,942−60,436 |
| GILEAD SCIENCES, INC. | 13,364 | reported | 30 Apr 2026 | tx 19+91,122−4,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 May 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 17,500 | — | 10b5-1 |
| 20 May 2026 | SALE | BioXcel Therapeutics, Inc. | 6,560 | 1.08 USD | 10b5-1 |
| 04 May 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 17,500 | 0.00 USD | 10b5-1deriv |
| 01 May 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 9,000 | — | |
| 01 May 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 9,000 | 0.00 USD | deriv |
| 30 Apr 2026 | GRANT_AWARD | GILEAD SCIENCES, INC. | 1,146 | 0.00 USD | |
| 30 Apr 2026 | GRANT_AWARD | GILEAD SCIENCES, INC. | 4,884 | 0.00 USD | deriv |
| 15 Mar 2026 | GRANT_AWARD | DAVITA INC. | 20,900 | 0.00 USD | |
| 15 Mar 2026 | GRANT_AWARD | DAVITA INC. | 56,506 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 35 | — | |
| 14 Mar 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 33 | — | |
| 14 Mar 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 33 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | BioXcel Therapeutics, Inc. | 35 | 0.00 USD | deriv |
| 01 Jan 2026 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 70,000 | 0.00 USD | deriv |
| 15 Dec 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 35 | — | |
| 14 Dec 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 33 | — | |
| 14 Dec 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 33 | 0.00 USD | deriv |
| 15 Dec 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 35 | 0.00 USD | deriv |
| 15 Nov 2025 | TAX_WITHHOLDING | DAVITA INC. | 5,165 | 121.55 USD | |
| 14 Sept 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 33 | — | |
| 15 Sept 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 35 | — | |
| 14 Sept 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 33 | 0.00 USD | deriv |
| 15 Sept 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 35 | 0.00 USD | deriv |
| 01 Aug 2025 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 9,000 | 0.00 USD | deriv |
| 22 Jul 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 625 | — |